Skip to main content

and
  1. No Access

    Article

    SMN regulates GEMIN5 expression and acts as a modifier of GEMIN5-mediated neurodegeneration

    GEMIN5 is essential for core assembly of small nuclear Ribonucleoproteins (snRNPs), the building blocks of spliceosome formation. Loss-of-function mutations in GEMIN5 lead to a neurodevelopmental syndrome among p...

    Tyler R. Fortuna, Sukhleen Kour, Anuradha Venkatakrishnan Chimata in Acta Neuropathologica (2023)

  2. Article

    Open Access

    LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice

    Spinobulbar muscular atrophy (SBMA) is caused by CAG expansions in the androgen receptor gene. Androgen binding to polyQ-expanded androgen receptor triggers SBMA through a combination of toxic gain-of-function...

    Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti in Nature Communications (2023)

  3. Article

    Open Access

    NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility

    A G4C2 hexanucleotide repeat expansion in the C9orf72 gene is the most common genetic cause of ALS and FTLD (C9-ALS/FTLD) with cytoplasmic TDP-43 inclusions observed in regions of neurodegeneration. The accumulat...

    Amanda M. Gleixner, Brandie Morris Verdone, Charlton G. Otte in Nature Communications (2022)

  4. No Access

    Article

    DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner

    Mutations in the RNA binding protein, Fused in Sarcoma (FUS), lead to amyotrophic lateral sclerosis (ALS), the most frequent form of motor neuron disease. Cytoplasmic aggregation and defective DNA repair machi...

    Tyler R. Fortuna, Sukhleen Kour, Eric N. Anderson, Caroline Ward in Acta Neuropathologica (2021)

  5. No Access

    Article

    Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway

    Nucleocytoplasmic transport (NCT) decline occurs with aging and neurodegeneration. Here, we investigated the NCT pathway in models of amyotrophic lateral sclerosis–fused in sarcoma (ALS–FUS). Expression of ALS...

    Yen-Chen Lin, Meenakshi Sundaram Kumar, Nandini Ramesh in Nature Neuroscience (2021)

  6. Article

    Open Access

    Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder

    GEMIN5, an RNA-binding protein is essential for assembly of the survival motor neuron (SMN) protein complex and facilitates the formation of small nuclear ribonucleoproteins (snRNPs), the building blocks of sp...

    Sukhleen Kour, Deepa S. Rajan, Tyler R. Fortuna, Eric N. Anderson in Nature Communications (2021)

  7. Article

    Open Access

    Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome

    Àngels García-Cazorla, Edgard Verdura, Natalia Juliá-Palacios in Acta Neuropathologica (2020)

  8. Article

    Open Access

    RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3

    The most common genetic cause of amyotrophic lateral sclerosis (ALS) is a GGGGCC (G4C2) hexanucleotide repeat expansions in first intron of the C9orf72 gene. The accumulation of repetitive RNA sequences can media...

    Nandini Ramesh, Elizabeth L. Daley in Acta Neuropathologica Communications (2020)

  9. Article

    Open Access

    RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM

    Amyotrophic lateral sclerosis (ALS) is an adult-onset, fatal neurodegenerative disease characterized by progressive loss of upper and lower motor neurons. While pathogenic mutations in the DNA/RNA-binding prot...

    Nandini Ramesh, Sukhleen Kour, Eric N. Anderson in Acta Neuropathologica Communications (2020)

  10. Article

    Open Access

    Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization

    Mutations in fused in sarcoma (FUS) lead to amyotrophic lateral sclerosis (ALS) with varying ages of onset, progression and severity. This suggests that unknown genetic factors contribute to disease pathogenesis....

    Ian Casci, Karthik Krishnamurthy, Sukhleen Kour in Nature Communications (2019)